Life Technologies SeCore® Sequence-Based Typing Workflow Submission to the United States Federal Food and Drug Administration (FDA) Press Releases and Articles

02/13/13

GenomeWeb Sequencing News

With 510(k) Clearance for 3500 Dx, Life Tech Aims to Convert HLA Typing Customers to Cleared Box, Assay

02/11/13Life Technologies press release

Life Technologies Receives FDA 510(k) Clearance for Diagnostic Use of Sanger Sequencing Platform and HLA Typing Kits

08/03/11

Clinical Sequencing News, GenomeWeb Daily News

Life Technologies Submits 3500 CE Machine and HLA Typing Kit for FDA 510(k) Approval

03/22/11

Clinical Sequencing News, GenomeWeb Daily News

Life Technologies Begins Clinical Trials of CE Sequencer for HLA Typing; Plans 510(k) Clearance

03/21/11

GenomeWeb Daily News

Life Technologies Starts Trials of Sequence-Based Typing System

03/21/11

Life Technologies press release

Life Technologies Initiates Clinical Trials Leading to 510(k) Submission of a Class I and Class II HLA Sequence-Based Typing Solution